DePuy Pinnacle Hip Lawsuits
A number of patients have reported experiencing problems with the DePuy Pinnacle hip replacement system, a metal-on-metal hip implant that has been linked to early failure, severe pain, dislocations and other complications. In many cases, these problems have led to the need for a hip revision surgery and resulted in permanent injuries.
DEPUY PINNACLE HIP REPLACEMENT LAWSUIT STATUS: Product liability lawyers are reviewing potential DePuy Pinnacle hip lawsuits for individuals who have experienced problems with their device, which may have been caused by design defects with the artificial hip.
Did You Know? Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
MANUFACTURER: DePuy Orthopaedics, Inc., a subsidiary of Johnson & Johnson
OVERVIEW: The DePuy Pinnacle hip replacement system is a line of metal-on-metal hip implants designed and manufactured by DePuy, a subsidiary of Johnson & Johnson.
The hip implant was approved by the FDA under the controversial 510(k) premarket approval system, which means that DePuy submitted the Pinnacle metal hip implants as substantially equivalent to devices that were already on the market and did not have to conduct rigorous pre-market approval testing.
Hundreds of reports involving DePuy Pinnacle hip problems have been filed with the FDA Adverse Event Reporting System, with many people experiencing problems while doing simple tasks like leaning forward, sitting down or straightening their legs. This has resulted in severe pain, dislocations and the need for hip revision surgery in many cases.
DEPUY PINNACLE METAL-ON-METAL HIP PROBLEMS: Orthopaedic surgeons and other health care professionals have been increasingly warning about problems with metal-on-metal hip implants, which can shed small metal particles into the body as the hip implants wear down over time, potentially resulting in metallosis and complications with the hip replacement.
The DePuy Pinnacle hip has been marketed to younger and more active patients, with indications that it is more durable and performs longer than metal-on-synthetic hip replacements. However, it now appears likely that the DePuy Pinnacle hip failure rate may be higher-than-expected, causing individuals to require additional surgery to replace or revise the hip replacement and accelerating the need for future hip replacements.
Similar reports of problems with another metal-on-metal hip replacement made by DePuy Orthopaedics resulted in a recall of DePuy ASR hip implants in August 2010. That recall came more than a year and a half after the first DePuy ASR hip lawsuit was filed against the company, alleging that design defects made the implant particularly prone to early failure.
Several individuals have already filed a DePuy Pinnacle lawsuit as a result of complications from their hip replacements. Some complaints allege that a DePuy Pinnacle hip recall should have been issued for the same reasons that the DePuy ASR hip replacement was pulled from the market. However, the manufacturer continues to market the DePuy Pinnacle hip system as a safe and effective hip replacement product.
DEPUY PINNACLE HIP REPLACEMENT LAWYERS: Attorneys are reviewing potential lawsuits for DePuy Pinnacle hip replacements for individuals who have experienced problems with the artificial hip. DePuy Pinnacle complications could include:
- Unexplained Hip Pain Several Months After Surgery
- Loosening of the DePuy Pinnacle Hip Replacement
- Hip Failure
- Additional Hip Replacement or Revision Surgery
"*" indicates required fields
More Top Stories
Gardasil vaccine lawyers seeking leadership positions in the consolidated federal litigation have begun submitting applications to the MDL court.
A wrongful death lawsuit claims Enfamil caused necrotizing enterocolitis in a preterm infant while she was NICU, resulting in her death after doctors determined her intestines were "non-salvageable."
State courts are being flooded with thousands of lawsuits over Zantac cancers which have not been included in the consolidated federal Multidistrict Litigation.